Since 2024: Glaring Reality Keeps AbbVie on Hold
AbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
BTC vs ETH fundamentals: a side-by-side look at core strengths and weaknesses to inform your next move.
27,640 articlesAbbVie’s stock has climbed since 2024, yet a stubborn balance sheet and looming biosimilar erosion create a cautious ...
Binance's XRP reserves fell to about 2.61 billion tokens, a trough not seen since February. XRP price briefly rebound...
IBM’s market collapse is forcing a reckoning on its future strategy as Microsoft and Apple deepen AI and cloud leader...
XRP sits around $1.08 as traders sift through diverging metrics and rising sentiment. Analysts warn that the price pr...
Bridgewater Associates tightened its tech exposure in the latest 13F filing, cutting stakes in Microsoft, Meta, and A...
Philanthropy headlines are buzzing as Warren Buffett shifts a long-standing gift pattern. This piece breaks down what...
IBM faces a tougher 2026 as AI and cloud shifts hit margins. With a sharp price drop and a sizable upside versus cons...
Bitcoin briefly peaked above $69k this week before pulling back toward $65k as equity markets turned lower and gold c...
Nvidia is reportedly developing a chip platform focused on AI inference workloads amid a shift in the AI landscape. E...
Inflation and higher rates have squeezed the classic 60/40 mix. Traders are turning to hard asset ETFs, including gol...
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
MercadoLibre, the region’s tech and payments titan, has tumbled from its June peak but continues to post rapid revenu...